R

Retension Pharmaceuticals Inc.
D

RTSN

12.410
USD
0.81
(6.98%)
مغلق
حجم التداول
1,938
الربح لكل سهم
0
العائد الربحي
-
P/E
-8
حجم السوق
103,395,144

العنوان: Retension Pharmaceuticals Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.